Terug
Dagbereik
€ 31,51
€ 34,34
52-Weeksbereik
€ 29,24
€ 48,75
Volume
695.481
50D / 200D Gem.
€ 35,89
/
€ 36,82
Vorige Slotkoers
€ 31,41
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 99,7 | 0,4 |
| P/B | 4,6 | 2,9 |
| ROE % | 5,1 | 3,7 |
| Net Margin % | 6,0 | 3,8 |
| Rev Growth 5Y % | 15,3 | 10,0 |
| D/E | 0,3 | 0,2 |
Belangrijkste Punten
Revenue grew 15,32% annually over 5 years — strong growth
Earnings grew 59,41% over the past year
Debt/Equity of 0,28 — conservative balance sheet
Generating 24,75M in free cash flow
P/E of 99,73 — premium valuation
Cash machine — converts 149,82% of earnings into free cash flow
Groei
Revenue Growth (5Y)
15,32%
Revenue (1Y)16,45%
Earnings (1Y)59,41%
FCF Growth (3Y)78,15%
Kwaliteit
Return on Equity
5,11%
ROIC1,83%
Net Margin5,98%
Op. Margin4,00%
Veiligheid
Debt / Equity
0,28
Current Ratio5,03
Interest Coverage7,10
Waardering
P/E Ratio
99,73
P/B Ratio4,64
EV/EBITDA148,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,45% | Revenue Growth (3Y) | 18,27% |
| Earnings Growth (1Y) | 59,41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 276,26M | Net Income (TTM) | 16,52M |
| ROE | 5,11% | ROA | 3,39% |
| Gross Margin | 74,42% | Operating Margin | 4,00% |
| Net Margin | 5,98% | Free Cash Flow (TTM) | 24,75M |
| ROIC | 1,83% | FCF Growth (3Y) | 78,15% |
| Safety | |||
| Debt / Equity | 0,28 | Current Ratio | 5,03 |
| Interest Coverage | 7,10 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 99,73 | P/B Ratio | 4,64 |
| P/S Ratio | 5,96 | PEG Ratio | 1,93 |
| EV/EBITDA | 148,99 | Dividend Yield | 0,00% |
| Market Cap | 1,65B | Enterprise Value | 1,65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 276,26M | 237,22M | 197,52M | 164,37M | 156,18M |
| Net Income | 16,52M | 10,36M | -3,18M | -16,71M | -7,47M |
| EPS (Diluted) | 0,32 | 0,20 | -0,07 | -0,35 | -0,16 |
| Gross Profit | 205,60M | 172,11M | 135,58M | 109,79M | 106,03M |
| Operating Income | 11,04M | 4,52M | -6,46M | -17,06M | -7,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 487,97M | 432,72M | 353,66M | 273,00M | 243,71M |
| Total Liabilities | 133,33M | 140,76M | 127,71M | 80,73M | 73,24M |
| Shareholders' Equity | 354,64M | 291,97M | 225,95M | 192,27M | 170,46M |
| Total Debt | 98,27M | 98,85M | 88,04M | 47,57M | 50,18M |
| Cash & Equivalents | 100,09M | 74,52M | 69,09M | 51,07M | 68,33M |
| Current Assets | 247,44M | 212,78M | 205,63M | 186,87M | 158,46M |
| Current Liabilities | 49,15M | 50,29M | 45,75M | 37,46M | 26,05M |